Search results for " Serou"

showing 4 items of 14 documents

Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis

2016

Abstract Background Safety of non-operative management for low-risk branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) is debated. Aim To perform a systematic review/meta-analysis to determine their risk of developing pancreatic malignancy and of pancreatic malignancy-related deaths. Methods A MEDLINE search was performed and methodology was based on PRISMA statement. Incidence rates of overall pancreatic malignancy, malignant BD-IPMN, IPMN-distinct PDAC, and of pancreatic malignancy-related death rates were calculated by dividing the total number of events by the total number of person-years (pyrs) of follow-up. Heterogeneity was determined by I2 statistic. Results 20 studies …

Oncologymedicine.medical_specialtyPancreatic malignancyendocrine system diseasesmedicine.medical_treatmentNon-operative managementGastroenterologyMalignant transformation03 medical and health sciencesPancreatectomy0302 clinical medicineRisk FactorsInternal medicinePancreatic cancermedicineHumansWatchful WaitingHepatologybusiness.industryFollow-upMortality ratePancreatic DuctsGastroenterologyPancreatic cancermedicine.diseasePancreatic NeoplasmsCell Transformation Neoplastic030220 oncology & carcinogenesisMeta-analysisPancreatectomyVery low risk030211 gastroenterology & hepatologyfollow-up; non-operative management; pancreatectomy; pancreatic cancerNeoplasms Cystic Mucinous and SerousbusinessWatchful waitingCarcinoma Pancreatic DuctalDigestive and Liver Disease
researchProduct

Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis

2019

Ovarian cancer and endometriosis are two distinct gynaecological conditions that share many biological aspects incuding proliferation, invasion of surrounding tissue, inflammation, inhibition of apoptosis, deregulation of angiogenesis and the ability to spread at a distance. miRNAs are small non-coding RNAs (19–22 nt) that act as post-transcriptional modulators of gene expression and are involved in several of the aforementioned processes. In addition, a growing body of evidence supports the contribution of oxidative stress (OS) to these gynaecological diseases: increased peritoneal OS due to the decomposition of retrograde menstruation blood facilitates both endometriotic lesion developmen…

endometriosis0301 basic medicineAngiogenesisEndometriosisInflammationReviewCatalysisendometriosis-associated ovarian cancerMalignant transformationlcsh:ChemistryInorganic Chemistry03 medical and health sciences0302 clinical medicinehigh-grade serous ovarian cancermicroRNAmedicineAnimalsHumansRNA NeoplasmEpithelial–mesenchymal transitionPhysical and Theoretical ChemistryCàncerlcsh:QH301-705.5Molecular BiologySpectroscopyOvarian Neoplasmsbusiness.industryOrganic ChemistrychemoresistanceGeneral Medicinemedicine.diseaseComputer Science ApplicationsMicroRNAsOxidative Stress030104 developmental biologymedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Ginecologia030220 oncology & carcinogenesismiRNAsCancer researchFemaleepithelial-to-mesenchymal transitionmedicine.symptombusinessOvarian cancerFallopian tubeInternational Journal of Molecular Sciences
researchProduct

Laparoscopic laterally extended pelvic resection for gynecological malignancies

2020

Lateral isolated gynecological cancer infiltrating the pelvic side wall has been considered non-operable with a poor oncological outcome.[1][1] The development of the laterally extended endopelvic resection and surgical progress for disease, overcoming the endopelvic fascia infiltrating muscles and

medicine.medical_specialtyCystadenocarcinomaLaparoscopesResection03 medical and health sciencesGynecologic Surgical Procedures0302 clinical medicinelaparoscopeGynecologic Surgical ProcedurelocalmedicineHumansAgedEndopelvic fasciaOvarian Neoplasms030219 obstetrics & reproductive medicineneoplasm recurrence localbusiness.industrySerousObstetrics and Gynecologyneoplasm recurrencemedicine.diseaseGynecological cancerCystadenocarcinoma SerousSurgerybody regionsCystadenocarcinoma SeroulaparoscopesSettore MED/40 - GINECOLOGIA E OSTETRICIAovarian cancerOncology030220 oncology & carcinogenesisFemaleLaparoscopybusinessOvarian cancer
researchProduct

Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single insti…

2019

ObjectiveTo determine the incidence of long term lymphadenectomy complications in primary surgery for endometrial cancer and to elucidate risk factors for these complications.MethodsA retrospective chart review was carried out for all patients with endometrial cancer managed at Parma University Hospital Unit of Gynecology and Obstetrics between 2010 and 2016. Inclusion criteria were surgical procedure including hysterectomy and lymphadenectomy (pelvic or pelvic and aortic). We identified patients with postoperative lymphocele and lower extremity lymphedema. Logistic regression analysis was used to identify predictive factors for postoperative complications.ResultsOf the 249 patients tested,…

medicine.medical_treatmentLymphoceleLymphocele0302 clinical medicinePostoperative ComplicationsCarcinosarcomaRisk FactorsLymphedema030219 obstetrics & reproductive medicineIncidenceLymph NodeObstetrics and GynecologyMiddle AgedPrognosisCystadenocarcinoma SerouDissectionLymphedemaOncologyItaly030220 oncology & carcinogenesisendometrial cancerFemaleHumanmedicine.medical_specialtyPelviPrognosiSentinel lymph nodeFollow-Up StudiePelvis03 medical and health sciencesmedicineHumansEndometrial NeoplasmAgedHysterectomybusiness.industryRisk FactorEndometrial cancerOdds ratiomedicine.diseaseSurgeryCystadenocarcinoma SerousEndometrial NeoplasmslymphadenectomyLymph Node ExcisionLymphadenectomyLymph NodesbusinessAdenocarcinoma Clear CellFollow-Up StudiesInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct